The Impact of the Provision of the COVID-19 Vaccine on Healthcare Stocks in Indonesia

Faridhatun Faidah (1), Rhealin Hening Karatri (2), Salman Alfarisi (3)
(1) Faculty of Economics and Business, Universitas Muria Kudus
(2) Faculty of Economics and Business, Universitas Muria Kudus
(3) Faculty of Mechanical System Engineering, Tokyo Metropolitan University
Fulltext View | Download
How to cite (SHIRKAH) :
Faidah, F., Karatri, R. H., & Alfarisi, S. (2022). The Impact of the Provision of the COVID-19 Vaccine on Healthcare Stocks in Indonesia. Shirkah: Journal of Economics and Business, 7(1), 49–69. https://doi.org/10.22515/shirkah.v7i1.433

The Coronavirus, which was firstly confirmed in Indonesia in 2020, had a hindering effect on the country's economy but a great impact on pharmaceutical companies. The first batch of vaccines that was administered in Indonesia on January 13, 2021, had a significant impact on healthcare stocks. This study examined the impact of the COVID-19 vaccine on healthcare stocks in Indonesia as seen from the stock price and the trading volume. Secondary data from 19 healthcare companies seven days before and seven days after the administration of COVID-19 vaccine was analyzed. Paired Samples t-test was carried out using the SPSS program. This study indicated that the administration of the COVID-19 vaccine has a strong impact in terms of increased changes in the healthcare stocks. Meanwhile, the trading volume decreased after the administration of the COVID-19 vaccine in Indonesia.The average of abnormal returns before and after the COVID-19 vaccine were at t-2, t+1, t+2, t+3, and t+7. Theoretically, the results of this discussion can be used as reference material for further research. In addition, it can be used in the development of knowledge in the field of stocks or pharmaceutical companies. The results of this study can practically be used as a reference for investors in making investment decisions.

Anwar, A. P. S., Jasuni, A. Y., & Juniarso, A. (2021). Single index model analysis for optimum portfolio in pharmaceutical companies registered in Indonesia Stock Exchange. Jurnal REKOMEN (Riset Ekonomi Manajemen), 4(2), 172-181. http://dx.doi.org/10.31002/rn.v4i2.3680

Arifin, B., & Anas, T. (2021). Lessons learned from COVID-19 vaccination in Indonesia: experiences, challenges, and opportunities. Human Vaccines & Immunotherapeutics, 17(11), 3898-3906. https://doi.org/10.1080/21645515.2021.1975450

Blaufus, K., Möhlmann, A., & Schwäbe, A. N. (2019). Stock price reactions to news about corporate tax avoidance and evasion. Journal of Economic Psychology, 72(June) 278-292. https://doi.org/10.1016/j.joep.2019.04.007

Bouattour, M. & Martinez, I. (2019). Efficient market hypothesis: An experimental study with uncertainty and asymmetric information. Finance Contrôle Stratégie, 22(4). https://doi.org/10.4000/fcs.3821

Burggraf, T., Fendel, R., & Huynh, T. L. D. (2019). Political news and stock prices: Evidence from Trump’s trade war. Applied Economics Letters, 27(18.), 431-436. https://doi.org/10.1080/13504851.2019.1690626

Chhetri, S. D. & Baral, R. P. (2018). Event study of effect of merger announcement on stock price in Nepal. Journal of Business and Management, 5(1), 64–73. https://doi.org/10.3126/jbm.v5i0.27390.

Fama, E. F. (1970). Efficient market: A review of theory and empirical work. Journal of Finance, 25(2), 383-417. https://doi.org/10.2307/2325486

Fernando, E., Putu, N., & Suryantini, S. (2018). Dampak pengumuman tax amnesty pada saham Lq-45. E-Jurnal Manajemen, 7(1), 360–386. https://doi.org/10.24843/EJMUNUD.2018.v7.i01.p14

Firmansyah, D. A. (2016). Analisis perbandingan trading volume activity dan abnormal return sebelum dan sesudah stock split. Jurnal Riset Manajemen, 5(5), 1-15.

He, B., Han, W. and Hon, S. (2022) A Machine Learning Approach: Enhancing the Predictive Performance of Pharmaceutical Stock Price Movement during COVID. Journal of Data Analysis and Information Processing, 10, 1-21. https://doi.org/10.4236/jdaip.2022.101001.

Indopremier.com (2020, 26 Desember). IPOTNEWS. Diakses pada 27 Desember 2020, dari https://www.indopremier.com/ipotnews

Jogiyanto, H.M. 2010. Teori portofolio dan analisis investasi (Edisi 3). Yogyakarta: BPFE.

Katadata.co.id. (2020, December 14). Saham Emiten BUMN Farmasi Lebih Diuntungkan di Masa Pandemi. Retrieved from https://katadata.co.id/safrezifitra/finansial/5f5f8b25991ca/saham-emiten-bumn-farmasi-lebih-diuntungkan-di-masa-pandemi

Khajar, I. (2016). Analisis stock split terhadap harga saham dan volume perdagangan saham indek Lq-45 periode 2010–2016. Jurnal Keuangan dan Perbankan, 20(3), 395–406. https://doi.org/10.26905/jkdp.v20i3.290.

Kusnandar, D. L. & Bintari, V. I. (2020). Perbandingan abnormal return saham sebelum dan sesudah perubahan waktu perdagangan selama pandemi COVID-19. Jurnal Pasar Modal Dan Bisnis, 2(2), 195–202. https://doi.org/10.37194/jpmb.v2i2.49

Lathifah, H. M., Febrianti, D. S., Utami, A. P., Ulhaq, A. A., Tulasmi, T., & Mukti, T. (2021). Dampak pandemi COVID-19 terhadap nilai harga saham syariah di Indonesia. Jurnal Ilmiah Ekonomi Islam, 7(1), 223-229. https://doi.org/10.29040/jiei.v7i1.1772

Liu, H., Manzoor, A., Wang, C., Zhang, L., & Manzoor, Z. (2020). The COVID-19 outbreak and affected the country's stock markets response. International Journal of Environmental Research and Public Health, 17(8), 1–19. https://doi.org/10.3390/ijerph17082800

MacKinlay, A. C. (1997). Event studies in economics and finance. Journal of Economic Literature, 35(1), 13-39. http://www.jstor.org/stable/2729691.

Market.bisnis.com. (2021, January 13). Valuasi sudah mahal, saham farmasi rawan koreksi. Retrieved from https://market.bisnis.com/read/20210113/189/1342218/valuasi-sudah-mahal-saham-farmasi-rawan-koreksi

Narayan. S., & Narayan, P. K. (2017). Are oil price news headlines statistically and economically significant for investors?. Journal of Behavioral Finance, 18(3), 258-270. https://doi.org/10.1080/15427560.2017.1308942

Nurmasari, I. (2020). Dampak COVID-19 terhadap perubahan harga saham dan volume transaksi. Jurnal Sekuritas (Saham, Ekonomi, Keuangan Dan Investasi), 3(3), 230–236. https://doi.org/10.52909/jbemk.v1i1.22

Pasanda, E. I. B., & Mildawati, T. (2015). Pengaruh pengumuman perubahan peringkat obligasi perusahaan terhadap reaksi pasar saham. Jurnal Ilmu Dan Riset Akuntansi (JIRA), 4(9), 1–14.

Rachman, R. & Ervina, D. (2017). Dampak pengumuman penerbitan obligasi perusahaan terhadap abnormal return saham di Indonesia tahun 2014-2015. MIX: Jurnal Ilmiah Manajemen, 7(2), 300-315. https://doi.org/10.22441/jurnal_mix

Rahmawati, N. L. & Prijati. Perbedaan Harga Saham Dan Volume Perdagangan Saham Sebelum Dan Sesudah Stock Split. Jurnal Ilmu Dan Riset Manajemen, 8(2), 1-15.

Summan, A., & Nandi, A. (2022). Timing of non-pharmaceutical interventions to mitigate COVID-19 transmission and their effects on mobility: a cross-country analysis. The European Journal of Health Economics, 23(1), 105-117. https://doi.org/10.1007/s10198-021-01355-4

Tambunan, D. (2020). Investasi saham di masa pandemi COVID-19. Widya Cipta: Jurnal Sekretari Dan Manajemen, 4(2), 117–123. https://doi.org/10.31294/widyacipta.v4i2.8564

Utami, Y. (2019). Indeks saham syariah Indonesia: Pergerakan harga dari perspektif asimetri informasi. Jurnal Inovasi Ekonomi, 4(02), 41–48. https://doi.org/10.22219/jiko.v4i2.9851

Wahyuni, R. & Widiasmara. (2017). Dampak pengumuman kemenangan donald trump pada pemilu presiden Amerika Serikat 2016 atau “Trump Effect†terhadap abnormal return saham Lq45 di BEI. Inventory: Jurnal Akuntansi, 1(1), 38-44. http://doi.org/10.25273/inventory.v1i1.4712

Welley, M. M., Oroh, F. N. S., & Walangitan, M. D. (2021). Perbandingan harga saham perusahaan farmasi bumn sebelum dan sesudah pengembangan vaksin virus Corona (COVID-19). JMBI UNSRAT (Jurnal Ilmiah Manajemen Bisnis Dan Inovasi Universitas Sam Ratulangi), 7(3), 571–579. https://doi.org/10.35794/jmbi.v7i3.31514

Winanti, A. (2021). Dampak COVID-19 terhadap harga saham bank syariah. Jurnal sekuritas, 4(2), 96–104. http://dx.doi.org/10.32493/skt.v4i2.6397

Woon, W. S. (2004). Introduction to the event study methodology. Singapore Management University, 4(7).

Yustisia, N. (2018). The Impact of stock split on the performance in Indonesian manufacturing companies. Binus Business Review, 9(1), 39-46. https://doi.org/10.21512/bbr.v9i1.3790

Copyright

Copyright aims to protect the specific way the article has been written to describe an experiment and the results. Shirkah: Journal of Economics and Business is committed to its authors to protect and defend their work and their reputation and takes allegations of infringement, plagiarism, ethical disputes, and fraud very seriously. Automotive Experiences is published under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Authors retain copyright and grant the journal right of first publication (online and print) with the work simultaneously. We use the restrictive license (non-commercial) as follows:

BY (attribution): Users are allowed to share, distribute and redistribute the published article in any medium or format, with an identification of the authors and its initial publication in this journal. Authors are encouraged to post and distribute their articles immediately after publication (e.g., institutional or public repositories, personal websites). Authors are allowed to enter into additional contractual arrangements for the non-exclusive distribution of the published and an acknowledgment of its initial publication in this journal.
NC (non-commercial): Users are not allowed to use the article commercially without the permission of the authors. Authors agree explicitly that the published article is indexed worldwide in databases, repositories and indexation services, even if these services operate on a commercial basis. Authors grant Shirkah: Journal of Economics and Business explicit the right to include the published articles in databases, repositories and indexation services. 

License

License to Publish

The non-commercial use of the article will be governed by the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). The author hereby grants Shirkah: Journal of Economics and Business an exclusive publishing and distribution license in the manuscript include tables, illustrations or other material submitted for publication as part of the manuscript in print, electronic and all other media (whether now known or later developed), in any form, in all languages, throughout the world, for the full term of copyright, and the right to license others to do the same, effective when the article is accepted for publication. This license includes the right to enforce the rights granted hereunder against third parties.

Author's Warranties

The author warrants that the article is original, written by stated author/s, has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).

User Rights

Under the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) license, the author(s) and users are free to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material). Users must give appropriate credit, provide a link to the license, and indicate if changes were made.

Rights of Authors

Authors retain the following rights:

  1. Copyright, and other proprietary rights relating to the article, such as patent rights,
  2. The right to use the substance of the article in future own works, including lectures and books,
  3. The right to reproduce the article for own purposes, provided the copies are not offered for sale, and
  4. The right to self-archive the article.

Co-Authorship

If the article was prepared jointly with other authors, the signatory of this form warrants that he/she has been authorized by all co-authors to sign this agreement on their behalf, and agrees to inform his/her co-authors of the terms of this agreement.

Royalties

This agreement entitles the author to no royalties or other fees. To such extent as legally permissible, the author waives his or her right to collect royalties relative to the article in respect of any use of the article by Shirkah: Journal of Economics and Business or its sublicensee.

Miscellaneous

Shirkah: Journal of Economics and Business will publish the article (or have it published) in the Journal if the article's editorial process is successfully completed and Shirkah: Journal of Economics and Business or its sublicensee has become obligated to have the article published. Shirkah: Journal of Economics and Business may conform the article to a style of punctuation, spelling, capitalization, and usage that it deems appropriate.